Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54,486,781
-
Total 13F shares
-
44,329,165
-
Share change
-
-129,569
-
Total reported value
-
$2,219,807,625
-
Put/Call ratio
-
97%
-
Price per share
-
$50.07
-
Number of holders
-
268
-
Value change
-
-$14,735,557
-
Number of buys
-
127
-
Number of sells
-
118
Institutional Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q3 2021
As of 30 Sep 2021,
Emergent BioSolutions Inc. - Common Stock (EBS) was held by
268 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,329,165 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Neuberger Berman Group LLC, JANUS HENDERSON GROUP PLC, STATE STREET CORP, EARNEST PARTNERS LLC, MANUFACTURERS LIFE INSURANCE COMPANY, THE, DIMENSIONAL FUND ADVISORS LP, NORTHERN TRUST CORP, and SNYDER CAPITAL MANAGEMENT L P.
This page lists
270
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.